Membrane Chromatography Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Membrane Chromatography Market

Membrane Chromatography Market Size, Share & Trends by Product (Cartridges, Capsules, Cassettes, Syringe Filters, Spin Column), Technique (Ion Exchange, Affinity), Operation Mode (Flow Through, Bind Elute), Material (PES, Cellulose, Hydrogel) - Global Forecast to 2029

FREE BROCHURE FREE SAMPLE REPORT
Report Code: BT 6006 Jun, 2024, by marketsandmarkets.com

Membrane Chromatography Market Size, Share & Trends

The size of global membrane chromatography market in terms of revenue was estimated to be worth $321 million in 2024 and is poised to reach $637 million by 2029, growing at a CAGR of 14.7% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth of the can be attributed to factors such as the rising demand for biopahramceuticals and increasing focus on advancement of biotechnology sector. However, restrictions on use of fluorinated substances and limited usage of membrane chromatography in large scale manufacturing may hamper the growth of the market.

Membrane Chromatography Market Trends

Membrane Chromatography Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Membrane Chromatography Market

Membrane Chromatography Market

Membrane Chromatography Market Dynamics

DRIVER: Increasing biopharmaceutical R&D

In recent years, companies are significantly investing in biopharmaceutical research & development (R&D) in order to cater to the increasing demand for biopharmaceuticals. Globally, the demand for biopharmaceuticals is increasing due to a significant rise in the number of chronic illnesses, such as cancer, diabetes, and neurological and cardiovascular conditions, worldwide. The growing R&D expenditure by biopharmaceutical companies is accelerating the growth of the market. For instance, according to AseBio, in 2022, R&D investments by biotech companies in Spain increased by 16% to reach USD 1,093.8 million (EUR 1,038 million).

RESTRAINT: Limited usage of membrane chromatography products in large scale manufacturing

Despite various advantages of membrane chromatography, such as high purity and productivity, its adoption continues to be slow in large-scale operations. This is primarily due to the challenges associated with scaling up membrane chromatography processes to meet the demands of large-scale manufacturing. Additionally, the technical issues associated with membrane chromatography such as membrane degradation and membrane fouling limit its application in large-scale manufacturing. Moreover, traditional column chromatography is a well-established technology in the bioprocessing industry. Thus, replacing conventional column chromatography technologies after making significant investments is challenging for end users. Also, factors such as the risk of disruption of the whole process, alteration in the purity and quality of the final product, and financial losses due to failure, hamper the adoption of membrane chromatography products in large-scale manufacturing. Thus, the limited use of membrane chromatography products in large-scale manufacturing is restraining the growth of the market.

OPPORTUNITY: Shift towards single-use technologies

Single-use membrane chromatography systems offer several advantages, including reduced risk of cross-contamination, faster turnaround times, and lower capital investment. The adoption of single-use technologies in bioprocessing is expected to grow, driven by the demand for cost-effective and flexible solutions. Companies are focusing on the adoption of single-use technologies through collaborations or partnerships for effective downstream purification processes. For instance, in December 2022, W. L. Gore & Associates, Inc. collaborated with AGC Biologics to improve downstream purification processes through increased productivity of the Protein A step, enabling a full single-use downstream process. The collaboration includes the family of GORE Protein Capture Devices with Protein A, which improves productivity in Protein A affinity purification and provides high binding capacity.

CHALLENGE: Presence of alternative techniques to chromatography

Precipitation, high-resolution ultrafiltration, crystallization, high-pressure refolding, charged ultra-filtration membranes, protein crystallization, capillary electrophoresis, aqueous two-phase extraction, and three-phase partitioning are some of the prominent techniques that are available as alternatives to chromatography. Alternative techniques such as protein crystallization, capillary electrophoresis, and aqueous two-phase extraction require fewer steps and a large volume of antibodies can be separated into a single step. This helps to reduce the manufacturing costs and helps to increase the manufacturing volume. Such benefits provided by alternative techniques are likely to hamper the growth of the market.

Global Membrane Chromatography Industry Ecosystem Analysis

The market ecosystem comprises raw material suppliers, membrane chromatography product manufacturers, and end users such as pharmaceutical and biopharmaceutical companies, CROs and CDMOs, and academic and research institutes. Membrane chromatography product products manufacturers provide syringe filters, filter plates, capsule, cassettes, cartridges, membrane sheets, and spin column.

Membrane Chromatography Market Ecosystem

The flow-through membrane chromatography segment dominated the membrane chromatography industry in 2023.

Based on technique, the membrane chromatography market is segmented into flow-through membrane chromatography and bind-elute membrane chromatography. In 2023, the flow-through membrane chromatography segment dominated the market owing to the focus on the development of biologics such as monoclonal antibodies. Moreover, the rising demand for an efficient mode of operation for chromatography is propelling the segment's growth in the market.

The pharmaceutical & biopharmaceutical companies segment dominated the membrane chromatography industry in 2023.

Based on the end user, the membrane chromatography market is segmented into pharmaceutical & biopharmaceutical companies, CROs and CDMOs, and academic and research institutes. In 2023, the pharmaceutical & biopharmaceutical companies segment held the largest market share in the global market owing to demand for biotherapeutics. Additionally, rising research and development spending for the advancement of the biopharmaceutical products is promoting segment growth in the market.

North America dominated the membrane chromatography industry in 2023.

Membrane Chromatography Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global membrane chromatography market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest share of market in 2023, followed by Europe and the Asia Pacific. Factors such as increasing development and manufacturing of biopharmaceuticals, significant investments in R&D activities, and presence of a well-established healthcare sector are responsible for the largest share of North America region in market.

Key players in the membrane chromatography market include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), 3M (US), Donaldson Company, Inc. (US), Cole-Parmer Instrument Company, LLC. (US), Restek Corporation (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), Microsolv (US), Cobetter (China), Regis Technologies Inc. (US), Nupore Filtration Systems (India), Sterlitech Corporation (US), Microlab Scientific Co., Ltd (China), Nantong Filterbio Membrane Co.,Ltd. (China), Hahnemühle FineArt GmbH (Germany), BIOCOMMA LIMITED (China), Clinivex (Canada), Greyhound Chromatography and Allied Chemicals Ltd (UK), Membrane Solutions (China).

Scope of the Membrane Chromatography Industry

Report Metric

Details

Market Revenue in 2024

$321 million

Projected Revenue by 2029

$637 million

Revenue Rate

Poised to Grow at a CAGR of 14.7%

Market Driver

Increasing biopharmaceutical R&D

Market Opportunity

Shift towards single-use technologies

This report categorizes the membrane chromatography market to forecast revenue and analyze trends in each of the following submarkets:

By Product
  • Capsules, Cassettes and Cartridges
  • Syringe Filters
  • Filter Plates
  • Spin Columns
  • Membrane Disc and Sheets
  • Other consumables & Accessories
By Technique
  • Ion Exchange Membrane Chromatography
    • Anion Exchange Membrane Chromatography
    • Cation Exchange Membrane Chromatography
  • Affinity Membrane Chromatography
  • Hydrophobic Interaction Membrane Chromatography
By Operation Mode
  • Flow-Through Membrane Chromatography
  • Bind-Elute Membrane Chromatography
By Membrane Material
  • Polyethersulfone (PES)
  • Cellulose
  • Hydrogel
  • Other Membrane Material
By End User
  • Pharmaceutical & Biopharmaceutical Companies
  • CROs and CDMOs
  • Academic and Research Institutes
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East
    • GCC Countries
      • Saudi Arabia (KSA)
      • United Arab Emirates (UAE)
      • Rest of GCC Countries (RoGCC)
    • Rest of Middle East (RoME)
  • Africa

Recent Developments of The Membrane Chromatography Industry:

  • In February 2024, Thermo Fisher Scientific Inc. opened a new sterile drug facility in Singapore to deliver new medicines and vaccines in the Asia Pacific market. The strategic investment complements new research capabilities at Thermo Fisher Scientific’s Customer Experience Center and Bioprocess Design Center. The Customer Experience Center includes 250 products across diverse fields, including molecular biology, genetic analysis sequencing, chromatography mass spectrometry, and cell therapy.
  • In January 2023, Agilent Technologies expanded its state-of-the-art manufacturing capacity of nucleic acid-based therapeutics. The company invested USD 725 million for this expansion.
  • In February 2022, Sartorius AG acquired Novasep’s chromatography division. The portfolio acquired comprises chromatography systems primarily suited for smaller biomolecules, such as oligonucleotides, peptides, and insulin, as well as innovative systems for continuous manufacturing of biologics. The acquisition aims to generate additional non-organic sales revenue for Sartorius AG.
  • In June 2021, 3M launched the 3M Harvest RC clarifier to deliver a single-stage purification solution for recombinant protein therapeutic manufacturing.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 32)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
    1.3 STUDY SCOPE 
           1.3.1 MARKET SEGMENTATION
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
    1.4 UNITS CONSIDERED 
           1.4.1 CURRENCY/VALUE UNITS
           1.4.2 VOLUME UNIT
    1.5 STAKEHOLDERS 
    1.6 LIMITATIONS 
    1.7 SUMMARY OF CHANGES 
    1.8 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 39)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: MEMBRANE CHROMATOGRAPHY MARKET
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 MEMBRANE CHROMATOGRAPHY INDUSTRY SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
                    FIGURE 5 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2023)
           2.2.2 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
           2.2.3 TOP-DOWN APPROACH
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 8 MARKET: CAGR PROJECTIONS
          TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 52)
    FIGURE 10 MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
    FIGURE 12 MARKET, BY OPERATION MODE, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 MARKET, BY MEMBRANE MATERIAL, 2024 VS. 2029 (USD MILLION)
    FIGURE 14 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 MEMBRANE CHROMATOGRAPHY MARKET OVERVIEW 
          FIGURE 16 INCREASING PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET
    4.2 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY INDUSTRY, BY TECHNIQUE AND COUNTRY (2023) 
          FIGURE 17 ION EXCHANGE MEMBRANE CHROMATOGRAPHY SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
    4.3 MARKET SHARE, BY PRODUCT, 2023 
          FIGURE 18 CAPSULES, CASSETTES, & CARTRIDGES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.4 MARKET SHARE, BY END USER, 2023 
          FIGURE 19 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT DOMINATED MARKET IN 2023
    4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 61)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 21 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 2 MEMBRANE CHROMATOGRAPHY MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Benefits offered by membrane chromatography over conventional chromatography techniques
                    5.2.1.2 Increasing biopharmaceutical R&D
                                FIGURE 22 TOTAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
                                TABLE 3 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
                    5.2.1.3 Increasing regulatory scrutiny on cleaning validation of downstream purification processes
                    5.2.1.4 Increasing production of biopharmaceuticals
                                FIGURE 23 ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US OR EU, 2012–2023
                                TABLE 4 THERAPEUTIC MONOCLONAL ANTIBODIES APPROVED IN EU OR US (2023–2024)
                    5.2.1.5 Expanded applications and diversification
           5.2.2 RESTRAINTS
                    5.2.2.1 Limited use of membrane chromatography products in large-scale manufacturing
                    5.2.2.2 Restrictions on use of fluorinated substances
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets
                    5.2.3.2 Patent expiry
                                TABLE 5 LIST OF BIOLOGICS LOSING PATENTS BETWEEN 2022 AND 2026
                    5.2.3.3 Shift toward single-use technologies
           5.2.4 CHALLENGES
                    5.2.4.1 Presence of alternative techniques to chromatography
                    5.2.4.2 Technical limitations associated with membrane chromatography
    5.3 TECHNOLOGY ANALYSIS 
           5.3.1 KEY TECHNOLOGIES
                    5.3.1.1 Ion exchange chromatography
                    5.3.1.2 Affinity chromatography
                    5.3.1.3 Hydrophobic interaction chromatography
                    5.3.1.4 Membrane technology
           5.3.2 COMPLEMENTARY TECHNOLOGIES
                    5.3.2.1 Process analytical technology
                                TABLE 6 APPLICATION OF PROCESS ANALYTICAL TECHNOLOGY IN MEMBRANE CHROMATOGRAPHY
                    5.3.2.2 Single-use technologies
           5.3.3 ADJACENT TECHNOLOGIES
                    5.3.3.1 Advanced material science
    5.4 TRADE DATA 
          TABLE 7 IMPORT VALUE FOR MACHINERY AND APPARATUS FOR FILTERING OR PURIFYING LIQUIDS, 2019–2023 (USD THOUSAND)
          TABLE 8 EXPORT VALUE FOR MACHINERY AND APPARATUS FOR FILTERING OR PURIFYING LIQUIDS, 2019–2023 (USD THOUSAND)
          TABLE 9 IMPORT VOLUME FOR MACHINERY AND APPARATUS FOR FILTERING OR PURIFYING LIQUIDS, 2019–2023 (UNITS)
          TABLE 10 EXPORT VOLUME FOR MACHINERY AND APPARATUS FOR FILTERING OR PURIFYING LIQUIDS, 2019–2023 (UNITS)
    5.5 SUPPLY CHAIN ANALYSIS 
          FIGURE 24 MEMBRANE CHROMATOGRAPHY INDUSTRY: SUPPLY CHAIN ANALYSIS
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 25 MARKET: VALUE CHAIN ANALYSIS
    5.7 PRICING ANALYSIS 
          TABLE 11 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2023
          TABLE 12 AVERAGE SELLING PRICE FOR MEMBRANE CHROMATOGRAPHY PRODUCTS, BY REGION
    5.8 ECOSYSTEM ANALYSIS 
          FIGURE 26 MARKET: ECOSYSTEM ANALYSIS
           5.8.1 RAW MATERIAL VENDORS IN MARKET
                    TABLE 13 MARKET: ROLE OF RAW MATERIAL VENDORS
           5.8.2 PRODUCT VENDORS IN MARKET
                    TABLE 14 MARKET: ROLE OF PRODUCT VENDORS
           5.8.3 END USERS IN MARKET
                    TABLE 15 MARKET: ROLE OF END USERS
           5.8.4 REGULATORY BODIES GOVERNING MARKET
                    TABLE 16 MARKET: ROLE OF REGULATORY BODIES
    5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
          FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
    5.10 PATENT ANALYSIS 
           5.10.1 METHODOLOGY
           5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
                     TABLE 17 PATENTS FILED, 2014–2024
                     FIGURE 28 PATENT APPLICATIONS FOR MARKET, JANUARY 2014–MAY 2024
                     TABLE 18 PATENTS IN MARKET
    5.11 KEY CONFERENCES & EVENTS 
           TABLE 19 MARKET: KEY CONFERENCES & EVENTS, 2024–2025
    5.12 REGULATORY LANDSCAPE 
           5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.12.2 REGULATORY SCENARIO
                     TABLE 24 MARKET: REGULATORY GUIDELINES
    5.13 PORTER’S FIVE FORCES ANALYSIS 
           FIGURE 29 MARKET: PORTER’S FIVE FORCES ANALYSIS
           TABLE 25 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF SUPPLIERS
           5.13.4 BARGAINING POWER OF BUYERS
           5.13.5 INTENSITY OF COMPETITIVE RIVALRY
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEMBRANE CHROMATOGRAPHY PRODUCTS
           5.14.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
           5.14.3 BUYING CRITERIA FOR MARKET
                     FIGURE 31 KEY BUYING CRITERIA FOR END USERS
                     TABLE 26 BUYING CRITERIA FOR MEMBRANE CHROMATOGRAPHY PRODUCTS, BY END USER
    5.15 INVESTMENT AND FUNDING SCENARIO 
 
6 MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT (Page No. - 101)
    6.1 INTRODUCTION 
          TABLE 27 MEMBRANE CHROMATOGRAPHY INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 28 MARKET, BY PRODUCT, 2022–2029 (THOUSAND UNITS)
    6.2 CAPSULES, CASSETTES, & CARTRIDGES 
           6.2.1 LARGEST AND FASTEST-GROWING PRODUCT SEGMENT
                    TABLE 29 CAPSULES, CASSETTES, & CARTRIDGES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 30 NORTH AMERICA: CAPSULES, CASSETTES, & CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 31 EUROPE: CAPSULES, CASSETTES, & CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 32 ASIA PACIFIC: CAPSULES, CASSETTES, & CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 33 LATIN AMERICA: CAPSULES, CASSETTES, & CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 34 MIDDLE EAST: CAPSULES, CASSETTES, & CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 35 GCC COUNTRIES: CAPSULES, CASSETTES, & CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 SYRINGE FILTERS 
           6.3.1 GROWING DEMAND IN LAB-SCALE PURIFICATION TO DRIVE MARKET
                    TABLE 36 SYRINGE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 37 NORTH AMERICA: SYRINGE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 38 EUROPE: SYRINGE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 39 ASIA PACIFIC: SYRINGE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 40 LATIN AMERICA: SYRINGE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 41 MIDDLE EAST: SYRINGE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 42 GCC COUNTRIES: SYRINGE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.4 FILTER PLATES 
           6.4.1 HIGHER FLOW-THROUGH RATE FOR FAST PURIFICATION TO SUPPORT MARKET GROWTH
                    TABLE 43 FILTER PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 44 NORTH AMERICA: FILTER PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 45 EUROPE: FILTER PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 46 ASIA PACIFIC: FILTER PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 47 LATIN AMERICA: FILTER PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 48 MIDDLE EAST: FILTER PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 49 GCC COUNTRIES: FILTER PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.5 SPIN COLUMNS 
           6.5.1 CONVENIENT PROCESSING OF MULTIPLE SMALL-SCALE SAMPLES TO PROPEL MARKET
                    TABLE 50 SPIN COLUMNS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 51 NORTH AMERICA: SPIN COLUMNS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 52 EUROPE: SPIN COLUMNS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 53 ASIA PACIFIC: SPIN COLUMNS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 54 LATIN AMERICA: SPIN COLUMNS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 55 MIDDLE EAST: SPIN COLUMNS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 56 GCC COUNTRIES: SPIN COLUMNS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.6 MEMBRANE DISCS & SHEETS 
           6.6.1 USED AS SEPARATION TOOLS IN VARIETY OF VIRAL AND PROTEIN PURIFICATION APPLICATIONS
                    TABLE 57 MEMBRANE DISCS & SHEETS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 58 NORTH AMERICA: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 59 EUROPE: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 60 ASIA PACIFIC: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 61 LATIN AMERICA: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 62 MIDDLE EAST: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 63 GCC COUNTRIES: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.7 OTHER CONSUMABLES & ACCESSORIES 
          TABLE 64 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 65 NORTH AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 66 EUROPE: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 67 ASIA PACIFIC: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 68 LATIN AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 69 MIDDLE EAST: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 70 GCC COUNTRIES: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
7 MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE (Page No. - 123)
    7.1 INTRODUCTION 
          TABLE 71 MEMBRANE CHROMATOGRAPHY INDUSTRY, BY TECHNIQUE, 2022–2029 (USD MILLION)
    7.2 ION EXCHANGE MEMBRANE CHROMATOGRAPHY 
          TABLE 72 MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 73 MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 74 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 75 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 76 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 77 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 78 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 79 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.1 ANION EXCHANGE MEMBRANE CHROMATOGRAPHY
                    7.2.1.1 Increasing adoption for monoclonal antibody purification to drive growth
                                TABLE 80 ANION EXCHANGE CHROMATOGRAPHY MEMBRANES: LIGAND FUNCTIONAL GROUPS
                                TABLE 81 MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 82 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 83 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 84 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 85 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 86 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 87 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.2 CATION EXCHANGE MEMBRANE CHROMATOGRAPHY
                    7.2.2.1 Increasing demand for advanced chromatographic techniques for biologics production to support market growth
                                TABLE 88 CATION EXCHANGE CHROMATOGRAPHY MEMBRANES: LIGAND FUNCTIONAL GROUPS
                                TABLE 89 CATION EXCHANGE BY REGION, 2022–2029 (USD MILLION)
                                TABLE 90 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 91 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 92 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 93 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 94 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 95 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 AFFINITY MEMBRANE CHROMATOGRAPHY 
           7.3.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO SUPPORT MARKET GROWTH
                    TABLE 96 MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 97 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 98 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 99 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 100 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 101 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 102 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    7.4 HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY 
           7.4.1 GROWING ADOPTION OF HIMC TECHNIQUE FOR BIOMOLECULE PURIFICATION TO PROPEL MARKET
                    TABLE 103 MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 104 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 105 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 106 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 107 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 108 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 109 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
8 MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE (Page No. - 143)
    8.1 INTRODUCTION 
          TABLE 110 MEMBRANE CHROMATOGRAPHY INDUSTRY, BY OPERATION MODE, 2022–2029 (USD MILLION)
    8.2 FLOW-THROUGH MEMBRANE CHROMATOGRAPHY 
           8.2.1 INCREASING FOCUS ON DEVELOPMENT OF BIOLOGICS TO DRIVE MARKET
                    TABLE 111 THERAPEUTIC MONOCLONAL ANTIBODIES APPROVED IN US OR EU IN 2023 & 2024
                    TABLE 112 MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 113 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 114 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 115 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 116 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 117 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 118 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 BIND-ELUTE MEMBRANE CHROMATOGRAPHY 
           8.3.1 INCREASING ADOPTION FOR BIOPHARMACEUTICALS MANUFACTURING TO AID MARKET GROWTH
                    TABLE 119 MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 120 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 121 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 122 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 123 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 124 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 125 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
9 MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL (Page No. - 152)
    9.1 INTRODUCTION 
          TABLE 126 MEMBRANE CHROMATOGRAPHY INDUSTRY, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
    9.2 POLYETHERSULFONE 
           9.2.1 INCREASING DEMAND FOR HIGH-QUALITY MEMBRANE MATERIALS TO DRIVE GROWTH
                    TABLE 127 MARKET FOR POLYETHERSULFONE, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 128 NORTH AMERICA: FOR POLYETHERSULFONE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 129 EUROPE: FOR POLYETHERSULFONE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 130 ASIA PACIFIC: FOR POLYETHERSULFONE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 131 LATIN AMERICA: FOR POLYETHERSULFONE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 132 MIDDLE EAST: FOR POLYETHERSULFONE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 133 GCC COUNTRIES: FOR POLYETHERSULFONE, BY COUNTRY, 2022–2029 (USD MILLION)
    9.3 CELLULOSE 
           9.3.1 STRONG, LIGHTWEIGHT, AND BIODEGRADABLE—KEY FACTORS DRIVING ADOPTION
                    TABLE 134 FOR CELLULOSE, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 135 NORTH AMERICA: FOR CELLULOSE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 136 EUROPE: FOR CELLULOSE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 137 ASIA PACIFIC: FOR CELLULOSE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 138 LATIN AMERICA: FOR CELLULOSE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 139 MIDDLE EAST: FOR CELLULOSE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 140 GCC COUNTRIES: FOR CELLULOSE, BY COUNTRY, 2022–2029 (USD MILLION)
    9.4 HYDROGEL 
           9.4.1 GROWING NEED TO REDUCE MEMBRANE FOULING TO BOOST MARKET GROWTH
                    TABLE 141 MARKET FOR HYDROGEL, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 142 MARKET FOR HYDROGEL, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 143 EUROPE: MARKET FOR HYDROGEL, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 144 ASIA PACIFIC: MARKET FOR HYDROGEL, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 145 LATIN AMERICA: MARKET FOR HYDROGEL, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 146 MIDDLE EAST: MARKET FOR HYDROGEL, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 147 GCC COUNTRIES: MARKET FOR HYDROGEL, BY COUNTRY, 2022–2029 (USD MILLION)
    9.5 OTHER MEMBRANE MATERIALS 
          TABLE 148 MARKET FOR OTHER MEMBRANE MATERIALS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 149 NORTH AMERICA: MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 150 EUROPE: MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 151 ASIA PACIFIC: MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 152 LATIN AMERICA: MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 153 MIDDLE EAST: MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 154 GCC COUNTRIES: MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
 
10 MEMBRANE CHROMATOGRAPHY MARKET, BY END USER (Page No. - 168)
     10.1 INTRODUCTION 
             TABLE 155 MEMBRANE CHROMATOGRAPHY INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
     10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 
             10.2.1 INCREASING NUMBER OF STRATEGIC ALLIANCES TO SUPPORT MARKET GROWTH
                        FIGURE 32 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
                        TABLE 156 MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 157 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 158 EUROPE: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 159 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 160 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 161 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 162 GCC COUNTRIES: MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
     10.3 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 
             10.3.1 RISING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET
                        TABLE 163 MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 164 NORTH AMERICA: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 165 EUROPE: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 166 ASIA PACIFIC: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 167 LATIN AMERICA: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 168 MIDDLE EAST: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 169 GCC COUNTRIES: MEMBRANE FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.4 ACADEMIC & RESEARCH INSTITUTES 
             10.4.1 SURGE IN R&D ACTIVITIES FOR DEVELOPMENT OF BIOPHARMACEUTICALS TO PROPEL MARKET
                        TABLE 170 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 171 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 172 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 173 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 174 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 175 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 176 GCC COUNTRIES: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
 
11 MEMBRANE CHROMATOGRAPHY MARKET, BY REGION (Page No. - 180)
     11.1 INTRODUCTION 
             TABLE 177 MEMBRANE CHROMATOGRAPHY INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
     11.2 NORTH AMERICA 
             TABLE 178 US: THERAPEUTIC MONOCLONAL ANTIBODIES APPROVED, 2023–2024
             11.2.1 RECESSION IMPACT ON NORTH AMERICAN MEMBRANE CHROMATOGRAPHY MARKET
                        FIGURE 33 NORTH AMERICA: MARKET SNAPSHOT
                        TABLE 179 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 180 NORTH AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 181 NORTH AMERICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 182 NORTH AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 183 NORTH AMERICA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 184 NORTH AMERICA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 185 NORTH AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.2.2 US
                        11.2.2.1 Patent expiry of biopharmaceuticals to support market growth
                                      FIGURE 34 TOTAL BIOTECHNOLOGY FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2013–2024
                                      TABLE 186 US: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 187 US: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 188 US: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 189 US: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 190 US: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 191 US: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing investments for advancement of biomanufacturing capacity to propel market
                                      TABLE 192 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 193 CANADA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 194 CANADA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 195 CANADA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 196 CANADA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 197 CANADA: MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.3 EUROPE 
             TABLE 198 EUROPE: LIST OF APPROVED MONOCLONAL ANTIBODY TREATMENTS
             11.3.1 RECESSION IMPACT ON EUROPEAN MEMBRANE CHROMATOGRAPHY MARKET
                        TABLE 199 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 200 EUROPE: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 201 EUROPE: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 202 EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 203 EUROPE: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 204 EUROPE: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 205 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Growing investments by key market players for advancement of biological drugs manufacturing capabilities to drive market
                                      TABLE 206 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 207 GERMANY: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 208 GERMANY: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 209 GERMANY: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 210 GERMANY: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 211 GERMANY: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.3 UK
                        11.3.3.1 Booming biotechnology industry to support market growth
                                      TABLE 212 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 213 UK: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 214 UK: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 215 UK: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 216 UK: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 217 UK: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 Increasing focus on advancement of bioproduction capacities to promote market growth
                                      TABLE 218 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 219 FRANCE: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 220 FRANCE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 221 FRANCE: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 222 FRANCE: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 223 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Growing biotech industry and rising R&D activities to propel market
                                      TABLE 224 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 225 ITALY: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 226 ITALY: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 227 ITALY: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 228 ITALY: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 229 ITALY: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Increasing number of biotechnology companies to propel market
                                      TABLE 230 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 231 SPAIN: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 232 SPAIN: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 233 SPAIN: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 234 SPAIN: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 235 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 236 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 237 REST OF EUROPE: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 238 REST OF EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 239 REST OF EUROPE: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 240 REST OF EUROPE: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 241 REST OF EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.4 ASIA PACIFIC 
             11.4.1 RECESSION IMPACT ON ASIA PACIFIC MEMBRANE CHROMATOGRAPHY MARKET
                        FIGURE 35 ASIA PACIFIC: MARKET SNAPSHOT
                        TABLE 242 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 243 AISA PACIFIC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 244 AISA PACIFIC: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 245 AISA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 246 AISA PACIFIC: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 247 AISA PACIFIC: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 248 AISA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 Growing focus on facility expansion to drive market
                                      TABLE 249 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 250 CHINA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 251 CHINA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 252 CHINA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 253 CHINA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 254 CHINA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.3 JAPAN
                        11.4.3.1 Growing government initiatives and increasing focus on facility expansion to propel market
                                      TABLE 255 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 256 JAPAN: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 257 JAPAN: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 258 JAPAN: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 259 JAPAN: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 260 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Growing number of biosimilar approvals to drive market
                                      TABLE 261 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 262 INDIA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 263 INDIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 264 INDIA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 265 INDIA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 266 INDIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.5 SOUTH KOREA
                        11.4.5.1 Growing strategic alliances for advancement of bioprocessing sector to support market growth
                                      TABLE 267 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 268 SOUTH KOREA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 269 SOUTH KOREA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 270 SOUTH KOREA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 271 SOUTH KOREA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 272 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.6 AUSTRALIA
                        11.4.6.1 Growing biopharmaceutical manufacturing industry to propel market
                                      TABLE 273 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 274 AUSTRALIA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 275 AUSTRALIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 276 AUSTRALIA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 277 AUSTRALIA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 278 AUSTRALIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                        TABLE 279 REST OF ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 280 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 281 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 282 REST OF ASIA PACIFIC: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 283 REST OF ASIA PACIFIC: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 284 REST OF ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.5 LATIN AMERICA 
             11.5.1 RECESSION IMPACT ON LATIN AMERICAN MEMBRANE CHROMATOGRAPHY MARKET
                        TABLE 285 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 286 LATIN AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 287 LATIN AMERICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 288 LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 289 LATIN AMERICA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 290 LATIN AMERICA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 291 LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.2 BRAZIL
                        11.5.2.1 Rising demand for biopharmaceuticals to drive market
                                      TABLE 292 BRAZIL: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 293 BRAZIL: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 294 BRAZIL: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 295 BRAZIL: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 296 BRAZIL: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 297 BRAZIL: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.3 MEXICO
                        11.5.3.1 Increasing government support for biopharmaceutical production to support market growth
                                      TABLE 298 MEXICO: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 299 MEXICO: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 300 MEXICO: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 301 MEXICO: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 302 MEXICO: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 303 MEXICO: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.4 REST OF LATIN AMERICA
                        TABLE 304 REST OF LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 305 REST OF LATIN AMERICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 306 REST OF LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 307 REST OF LATIN AMERICA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 308 REST OF LATIN AMERICA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 309 REST OF LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.6 MIDDLE EAST 
             11.6.1 RECESSION IMPACT ON MIDDLE EAST MEMBRANE CHROMATOGRAPHY MARKET
                        TABLE 310 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 311 MIDDLE EAST: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 312 MIDDLE EAST: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 313 MIDDLE EAST: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 314 MIDDLE EAST: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 315 MIDDLE EAST: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 316 MIDDLE EAST: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.6.2 GCC COUNTRIES
                        TABLE 317 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 318 GCC COUNTRIES: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 319 GCC COUNTRIES: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 320 GCC COUNTRIES: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 321 GCC COUNTRIES: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 322 GCC COUNTRIES: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 323 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
                        11.6.2.1 Saudi Arabia
                                     11.6.2.1.1 Increasing focus on advancements in healthcare sector to drive market
                                                      TABLE 324 SAUDI ARABIA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                                      TABLE 325 SAUDI ARABIA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                                      TABLE 326 SAUDI ARABIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 327 SAUDI ARABIA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                                      TABLE 328 SAUDI ARABIA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                                      TABLE 329 SAUDI ARABIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
                        11.6.2.2 United Arab Emirates
                                     11.6.2.2.1 Advancements in biopharmaceutical sector to propel market growth
                                                      TABLE 330 UNITED ARAB EMIRATES: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                                      TABLE 331 UNITED ARAB EMIRATES: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                                      TABLE 332 UNITED ARAB EMIRATES: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 333 UNITED ARAB EMIRATES: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                                      TABLE 334 UNITED ARAB EMIRATES: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                                      TABLE 335 UNITED ARAB EMIRATES: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
                        11.6.2.3 Rest of GCC Countries
                                      TABLE 336 REST OF GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 337 REST OF GCC COUNTRIES: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                                      TABLE 338 REST OF GCC COUNTRIES: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 339 REST OF GCC COUNTRIES: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                                      TABLE 340 REST OF GCC COUNTRIES: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 341 REST OF GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.6.3 REST OF MIDDLE EAST
                        TABLE 342 REST OF MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 343 REST OF MIDDLE EAST: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 344 REST OF MIDDLE EAST: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 345 REST OF MIDDLE EAST: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 346 REST OF MIDDLE EAST: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 347 REST OF MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.7 AFRICA 
             11.7.1 RISING FUNDING FOR DEVELOPMENT AND MANUFACTURING OF BIOPHARMACEUTICALS TO AID MARKET GROWTH
             11.7.2 RECESSION IMPACT ON AFRICAN MEMBRANE CHROMATOGRAPHY MARKET
                        TABLE 348 AFRICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 349 AFRICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
                        TABLE 350 AFRICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 351 AFRICA: MARKET, BY OPERATION MODE, 2022–2029 (USD MILLION)
                        TABLE 352 AFRICA: MARKET, BY MEMBRANE MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 353 AFRICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 266)
     12.1 OVERVIEW 
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET
                        TABLE 354 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
     12.3 REVENUE ANALYSIS 
             FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY INDUSTRY, 2021–2023 (USD MILLION)
             TABLE 355 REVENUE ANALYSIS OF KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY INDUSTRY, 2021–2023 (USD MILLION)
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 37 MEMBRANE CHROMATOGRAPHY INDUSTRY SHARE ANALYSIS, BY KEY PLAYER (2023)
             TABLE 356 MEMBRANE CHROMATOGRAPHY INDUSTRY: DEGREE OF COMPETITION
     12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 38 MEMBRANE CHROMATOGRAPHY INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        12.5.5.1 Company footprint
                                      FIGURE 39 MEMBRANE CHROMATOGRAPHY INDUSTRY: COMPANY FOOTPRINT
                        12.5.5.2 Product footprint
                                      TABLE 357 MEMBRANE CHROMATOGRAPHY INDUSTRY: PRODUCT FOOTPRINT
                        12.5.5.3 Region footprint
                                      TABLE 358 MEMBRANE CHROMATOGRAPHY INDUSTRY: REGION FOOTPRINT
                        12.5.5.4 Technique footprint
                                      TABLE 359 MEMBRANE CHROMATOGRAPHY INDUSTRY: TECHNIQUE FOOTPRINT
                        12.5.5.5 Membrane material footprint
                                      TABLE 360 MEMBRANE CHROMATOGRAPHY INDUSTRY: MEMBRANE MATERIAL FOOTPRINT
     12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
                        FIGURE 40 MEMBRANE CHROMATOGRAPHY INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
     12.7 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 
             TABLE 361 MEMBRANE CHROMATOGRAPHY INDUSTRY: DETAILED LIST OF KEY STARTUP/SME PLAYERS
             TABLE 362 MEMBRANE CHROMATOGRAPHY INDUSTRY: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
     12.8 VALUATION AND FINANCIAL METRICS 
             FIGURE 41 EV/EBITDA OF KEY VENDORS
             FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
     12.9 BRAND/PRODUCT COMPARISON 
             FIGURE 43 MEMBRANE CHROMATOGRAPHY INDUSTRY: BRAND/PRODUCT COMPARATIVE ANALYSIS
     12.1 COMPETITIVE SCENARIO 
             12.10.1 PRODUCT LAUNCHES
                        TABLE 363 MEMBRANE CHROMATOGRAPHY INDUSTRY: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024
             12.10.2 DEALS
                        TABLE 364 MEMBRANE CHROMATOGRAPHY INDUSTRY: DEALS, JANUARY 2021–APRIL 2024
             12.10.3 EXPANSIONS
                        TABLE 365 MEMBRANE CHROMATOGRAPHY INDUSTRY: EXPANSIONS, JANUARY 2021–APRIL 2024
 
13 COMPANY PROFILES (Page No. - 287)
     13.1 INTRODUCTION 
(Business overview, Products offered, Recent developments & MnM View)*
     13.2 KEY PLAYERS 
             13.2.1 DANAHER CORPORATION
                        TABLE 366 DANAHER CORPORATION: COMPANY OVERVIEW
                        FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 367 DANAHER CORPORATION: PRODUCTS OFFERED
             13.2.2 SARTORIUS AG
                        TABLE 368 SARTORIUS AG: COMPANY OVERVIEW
                        FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2023)
                        TABLE 369 SARTORIUS AG: PRODUCTS OFFERED
                        TABLE 370 SARTORIUS AG: DEALS, JANUARY 2021–APRIL 2024
                        TABLE 371 SARTORIUS AG: EXPANSIONS, JANUARY 2021–APRIL 2024
             13.2.3 MERCK KGAA
                        TABLE 372 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023)
                        TABLE 373 MERCK KGAA: PRODUCTS OFFERED
                        TABLE 374 MERCK KGAA: EXPANSIONS, JANUARY 2021–APRIL 2024
             13.2.4 THERMO FISHER SCIENTIFIC INC.
                        TABLE 375 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
                        FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
                        TABLE 376 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
                        TABLE 377 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–APRIL 2024
             13.2.5 3M
                        TABLE 378 3M: BUSINESS OVERVIEW
                        FIGURE 48 3M: COMPANY SNAPSHOT (2023)
                        TABLE 379 3M: PRODUCTS OFFERED
                        TABLE 380 3M: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024
                        TABLE 381 3M: DEALS, JANUARY 2021–APRIL 2024
             13.2.6 AGILENT TECHNOLOGIES, INC.
                        TABLE 382 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
                        FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
                        TABLE 383 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
                        TABLE 384 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–APRIL 2024
                        TABLE 385 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–APRIL 2024
             13.2.7 DONALDSON COMPANY, INC.
                        TABLE 386 DONALDSON COMPANY, INC.: COMPANY OVERVIEW
                        FIGURE 50 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2023)
                        TABLE 387 DONALDSON COMPANY, INC.: PRODUCTS OFFERED
                        TABLE 388 DONALDSON COMPANY, INC.: DEALS, JANUARY 2021–APRIL 2024
             13.2.8 COLE-PARMER INSTRUMENT COMPANY, LLC
                        TABLE 389 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW
                        TABLE 390 COLE-PARMER INSTRUMENT COMPANY, LLC: PRODUCTS OFFERED
             13.2.9 RESTEK CORPORATION
                        TABLE 391 RESTEK CORPORATION: COMPANY OVERVIEW
                        TABLE 392 RESTEK CORPORATION: PRODUCTS OFFERED
             13.2.10 BIO-RAD LABORATORIES, INC.
                        TABLE 393 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
                        FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
                        TABLE 394 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
                        TABLE 395 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024
             13.2.11 SHIMADZU CORPORATION
                        TABLE 396 SHIMADZU CORPORATION: COMPANY OVERVIEW
                        FIGURE 52 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 397 SHIMADZU CORPORATION: PRODUCTS OFFERED
             13.2.12 W. L. GORE & ASSOCIATES, INC.
                        TABLE 398 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
                        TABLE 399 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
                        TABLE 400 W. L. GORE & ASSOCIATES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024
                        TABLE 401 W. L. GORE & ASSOCIATES, INC.: DEALS, JANUARY 2021–APRIL 2024
             13.2.13 MACHEREY-NAGEL GMBH & CO. KG
                        TABLE 402 MACHEREY-NAGEL GMBH & CO. KG: BUSINESS OVERVIEW
                        TABLE 403 MACHEREY-NAGEL GMBH & CO. KG: PRODUCTS OFFERED
             13.2.14 MICROSOLV
                        TABLE 404 MICROSOLV: COMPANY OVERVIEW
                        TABLE 405 MICROSOLV: PRODUCTS OFFERED
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
     13.3 OTHER PLAYERS 
             13.3.1 COBETTER
                        TABLE 406 COBETTER: BUSINESS OVERVIEW
             13.3.2 REGIS TECHNOLOGIES INC.
                        TABLE 407 REGIS TECHNOLOGIES INC.: BUSINESS OVERVIEW
             13.3.3 NUPORE FILTRATION SYSTEMS
                        TABLE 408 NUPORE FILTRATION SYSTEMS: BUSINESS OVERVIEW
             13.3.4 STERLITECH CORPORATION
                        TABLE 409 STERLITECH CORPORATION: BUSINESS OVERVIEW
             13.3.5 MICROLAB SCIENTIFIC CO., LTD.
                        TABLE 410 MICROLAB SCIENTIFIC CO., LTD.: BUSINESS OVERVIEW
             13.3.6 NANTONG FILTERBIO MEMBRANE CO., LTD.
                        TABLE 411 NANTONG FILTERBIO MEMBRANE CO., LTD.: COMPANY OVERVIEW
             13.3.7 HAHNEMÜHLE FINEART GMBH
                        TABLE 412 HAHNEMÜHLE FINEART GMBH: COMPANY OVERVIEW
             13.3.8 BIOCOMMA LIMITED
                        TABLE 413 BIOCOMMA LIMITED: BUSINESS OVERVIEW
             13.3.9 CLINIVEX
                        TABLE 414 CLINIVEX: BUSINESS OVERVIEW
             13.3.10 GREYHOUND CHROMATOGRAPHY AND ALLIED CHEMICALS LTD.
                        TABLE 415 GREYHOUND CHROMATOGRAPHY AND ALLIED CHEMICALS LTD.: BUSINESS OVERVIEW
             13.3.11 MEMBRANE SOLUTIONS
                        TABLE 416 MEMBRANE SOLUTIONS: BUSINESS OVERVIEW
 
14 APPENDIX (Page No. - 341)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global membrane chromatography market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the membrane chromatography market. The secondary sources used for this study include World Health Organization (WHO), United States Food and Drug Administration (FDA), Chinese American Chromatography Association, Chromatography Institute of America, International Separation Science Society, National Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of America (PhRMA), Organisation for Economic Co-operation and Development (OECD), European Federation of Pharmaceutical Industries and Associations, National Center for Biotechnology Information (NCBI), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global membrane chromatography market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, CROs and CMOs, academic and research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 60% and 40% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Membrane Chromatography Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the membrane chromatography market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the membrane chromatography business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Membrane Chromatography Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Membrane Chromatography Market Size, and Share

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Membrane chromatography is a separation technique used in separation and purification processes. It involves the use of membranes as the stationary phase for chromatographic separations. Membrane chromatography utilizes chromatographic principles to separate molecules based on their interactions with a stationary phase immobilized on the membrane surface. This stationary phase can be based on various mechanisms such as ion exchange, affinity interactions, or hydrophobic interactions. Molecules that interact strongly with the stationary phase are retained longer on the membrane, while others pass through more quickly.

Stakeholders

  • Membrane Chromatography Product Manufacturers, Vendors, and Distributors
  • Academic and Research Institutes
  • Pharmaceutical and Biopharmaceutical Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)

Report Objectives

  • To define, describe, segment, and forecast the membrane chromatography market based on product, technique, operation mode, membrane material, end user, and region
  • To provide detailed information about the major factors influencing the market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall membrane chromatography market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
  • To strategically profile the key players in the membrane chromatography market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments, such as product launches, acquisitions, collaborations, expansions, and partnerships in the membrane chromatography market
  • To benchmark players within the membrane chromatography market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Geographical Analysis

  • A further breakdown of the Rest of Europe  membrane chromatography market into countries
  • A further breakdown of the Rest of Asia Pacific membrane chromatography market into countries
  • A further breakdown of the Rest of Latin American membrane chromatography market into countries
  • A further breakdown of the Rest of Middle East membrane chromatography market into countries
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 6006
Published ON
Jun, 2024
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Membrane Chromatography Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback